C

Cabio Biotech Wuhan Co Ltd
SSE:688089

Watchlist Manager
Cabio Biotech Wuhan Co Ltd
SSE:688089
Watchlist
Price: 22.85 CNY 0.09% Market Closed
Market Cap: 3.8B CNY

Cabio Biotech Wuhan Co Ltd
Investor Relations

Cabio Biotech Wuhan Co Ltd is a China-based company principally engaged in biotechnology business. The Company is mainly engaged in the research and development, production and sales of polyunsaturated fatty acids arachidonic acid (ARA), algal oil docosahexaenoic acid (DHA) and sialic acid (SA), and natural beta-carotene products. Its products are mainly used in infant formula food, dietary supplements, nutritional health food and formula food for special medical purposes. The Company integrates industrial strain-oriented optimization technology, fermentation fine control technology, and efficient separation, purification and preparation technology, and provides nutrient products and innovative solutions for customers in the global nutrition and health field through sustainable microbial synthesis and manufacturing methods. The Company mainly conducts its business in domestic and overseas markets.

Show more
Loading
688089
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Dewei Yi
Chairman & GM
No Bio Available
Mr. Huabiao Wang
Financial Director & Director
No Bio Available
Mr. Huarong Yi
Deputy GM & Secretary of the Board of Directors
No Bio Available
Mr. Tao Ma
Deputy General Manager
No Bio Available
Hao Xiong
Accounting Supervisor
No Bio Available

Contacts

Address
HUBEI
Wuhan
No.999, High-Tech Avenue, East Lake High-tech Development Zone
Contacts
+862767845289
www.cabio.cn